Phibro makes progress on ASF vaccine

Phibro Animal Health Corporation has announced they are pursuing a patent for their developing African Swine Fever vaccine.

CEO Jack Bendheim says the group of peptides and proteins that’s been identified is a significant step toward finding a solution to the devastating disease.

Researchers within the company are creating an epitope-based vaccine which could treat ASF and stop the spread by creating a protective immune response in animals.

The USDA previously has given a notice of intent to license a preventative vaccine for African Swine Fever to Zoetis and a Bulgarian pharmaceutical company.  Vaccines are also in development in China, Vietnam, and the UK.

Add Comment

Your email address will not be published.


stay up to date

Subscribe for our newsletter today and receive relevant news straight to your inbox!